TASA ID: 1351

I.  Background Information

Benzene is a clear, colorless liquid at ambient temperatures. Benzene has a relatively high vapor pressure and thus evaporates quickly into the air.  The odor threshold for benzene has been reported as 12 parts per million. Benzene occurs naturally in crude oil and is widely used in industry as a raw material for the production of other organic chemicals.  Most gasolines sold in this country contain between one and two percent benzene (World Health Organization, 1993; ACGIH, 2001; Bruckner, et al., 2008). Benzene is present in most outdoor and indoor environments. Most benzene exposures to the general public are associated with the use of gasoline powered vehicles and other equipment. Benzene is also found in some consumer products and is present in main stream and side stream tobacco smoke (Wallace, 1996).

II.  Summary of Health Effects of Benzene Exposure

A.  Non-cancer Health Effects

1.  Effects of short-term exposures

The acute effects of over-exposure to benzene are well known in general terms. Effects on the central nervous system predominate, but benzene exposure can also cause irritation, cardiovascular effects, and effects on the kidney. There is little quantitative data in the toxicity literature concerning human health effects associated with acute exposures to benzene.  

Volunteers exposed for eight hours to 25 parts per million (ppm) of benzene suffered no ill effects. Headache, lassitude, and weariness were reported when six-hour exposures of 50-150 ppm were encountered. Exposures to 500 or more ppm for one hour caused headache and other ill effects. Acute exposures to high levels of benzene can cause eye, skin, and respiratory irritation; difficulty breathing; cardiovascular effects such as ventricular fibrillation; gastritis; kidney congestion; and neurological effects, such as distal neuropathy, abnormalities in nerve conduction velocity, difficulty sleeping, and memory loss (Cavender, 1996).  At very high levels of exposure confusion, convulsive movements, paralysis, and death can occur (Cavender, 1996; Galbraith, et al., 2010).

2. Effects of longer-term exposures

Intermediate and chronic exposures to benzene cause a variety of pathological states. These include cytopenia (anemia, leukopenia, or thrombocytopenia) which is a decrease in various cellular elements of the circulating blood; central nervous system effects such as headache, dizziness, fatigue, anorexia, visual disturbances, and hearing loss; and respiratory irritation evidenced by difficulty breathing (ATSDR, 2007; Cavender, 1996). Benzene has also been shown to be an immunosuppressive agent (Synder, 1984).

B.  Cancer

The critical effect of chronic benzene exposure is an increased risk of cancer. Chronic benzene exposure has been shown to cause myelodysplastic syndrome which can progress to leukemia (Synder, 2002; Bruckner, et al., 2008). Benzene can also cause chromosomal aberrations in humans.  Chromosomal analyses have been used in investigations of benzene exposures (Zhang, et al., 2002).

III.  Historical Aspects of Knowledge of Benzene Toxicity

The fact that benzene exposure can cause chronic, as well as acute effects was first noted as early as 1897.  Animal experiments and occupational exposure studies conducted in the early part of the 20th century showed long-term benzene exposure particularly affects the hematopoietic system (Ferguson, et al., 1933).  An early article published in the Journal of the American Medical Association described the types of effects to be expected from occupational exposures to benzene (McCord, 1929).  More reports of benzene toxicity continued to become available in the 1930s and 1940s.

In the early 1940s, many industries were abandoning the use of benzene as a solvent (Gafafer, 1943). A widely-quoted report issued in the late 1940s by the American Petroleum Institute noted the effects of acute and chronic benzene exposure.  While recommending a 50 parts per million (ppm) occupational standard, they stated the only "absolutely safe" level of benzene exposure was zero (API, 1948).

An association between long-term benzene exposure and human leukemia was suggested by a series of case reports beginning in the 1930s up through the 1960s (Galbraith, et al., 2010).  Subsequent epidemiologic studies carried out beginning in the 1970s confirmed those findings (Rinsky, et al., 1981; Rinsky, et. al., 1987).  Various organizations have now concluded there is a causal relationship between excess benzene exposure and the development of acute myelogenous leukemia (WHO, 1993; NTP, 2005; ATSDR, 2007).

IV.  Health-Based Exposure Standards and Guidelines for Benzene 

Benzene is considered to be a known human carcinogen by Occupational Safety and Health Administration (OSHA), the Environmental Protection Agency (EPA), the National Institute for Occupational Safety and Health (NIOSH), the American Conference of Governmental Industrial Hygienists (ACGIH), and the International Agency for Research on Cancer (IARC) among others.

Occupational exposure guidelines and standards have decreased markedly over the years. Up until 1948, 100 ppm was considered a safe level to which workers could be exposed for 8 hours a day, 5 days a week, over a working lifetime.  Exposure guidelines were revised downwards to 50 ppm in 1948; 35 ppm in 1949; 25 ppm in 1957; and 10 ppm in 1972. In 1987, the Occupational Health and Safety Administration reduced the occupational exposure limit to its current value (Galbraith, et al., 2010).

Several occupational exposure standards and guidelines currently exist for benzene. The Occupational Safety and Health Administration (OSHA) has set a Permissible Exposure Limit at 1 ppm as an 8-hour average and a Short Term Exposure Limit (STEL) of 5 ppm as a 15-minute average. The National Institute for Occupational Safety and Health Recommended Exposure Limit is and 8-hour limit of 0.1 ppm and their STEL is 1 ppm (NIOSH, 2007).  The American Conference of Governmental Industrial Hygienists has set a Threshold Limit Value of 0.5 ppm as an 8-hour average and a 15-minute average STEL of 2.5 ppm (ACGIH, 2014). These levels have been set to protect workers from the adverse effects of benzene exposure, including cancer.

Other agencies and organizations have also set exposure guidelines for community exposures to benzene. The Agency for Toxic Substances and Disease Registry (ATSDR) has set “Minimal Risk Levels” for benzene of 0.009 ppm for a 24-hour exposure, 0.006 ppm for exposures lasting from 1 to 14 days, and 0.003 ppm for longer exposure periods.  These are levels that are believed to be without risk for adverse health effects (ATSDR, 2009). The American Industrial Hygiene Association, in conjunction with the U.S. Department of Defense, has set “Emergency Response Planning Guidelines” for benzene. They have established that a one-hour exposure to 50 ppm of benzene can cause mild, transient health effects; a one-hour exposure to 150 ppm could cause serious transient or irreversible health effects; and a one-hour exposure to 1,000 ppm of benzene could be life-threatening (AIHA, 2010).

IV.  Summary

Benzene is widely used in industry and is present at low levels in most outdoor and indoor environments. Exposure to elevated levels of benzene can cause a variety of adverse health effects.  Non-cancer effects of over-exposure to benzene include effects on the respiratory system, the nervous system, the cardiovascular system, the gastrointestinal system, and the kidney.  Benzene is a known human carcinogen.  Benzene exposure has been shown to cause acute myelogenous leukemia in humans.


Agency for Toxic Substances and Disease Registry (2007), "Toxicological Profile for Benzene," available at http://www.atsdr.cdc.gov/ToxProfiles/tp3.pdf

Agency for Toxic Substances and Disease Registry (2009), "Minimal Risk Levels,” available at http://www.atsdr.cdc.gov/mrls/index.html

American Conference of Governmental Industrial Hygienists (2014), "TLVs and BEIs: Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents," ACGIH Press, Cincinnati, OH.

American Industrial Hygiene Association (2010), “ERPG/WEEL Handbook,” available at http://www.aiha.org/foundations/GuidelineDevelopment/ERPG/Documents/ERPG_Values2010.pdf

Bruckner, J.V., S.S. Anand, and D.A. Warren (2008), “Toxic Effects of Solvents and Vapors.” Chapter 24 in Casarett and Doull’s Toxicology, 7th Edition, C.D. Klaasen, editor, McGraw Hill Medical, New York, pp. 1007-1010.

Cavender, F., “Aromatic Hydrocarbons” (1994), Chapter 21 in Patty's Industrial Hygiene and Toxicology, Volume IIB, fourth edition, John Wiley and Sons, New York, pp.1306-1326.

Galbraith, D., S.A. Gross, and D. Paustenbach (2010), "Benzene and Human Health: A Historical Review and Appraisals of Associations with Various Diseases," Critical Reviews in Toxicology 40(S2):1-46.

Gefafer, W.M., Manual of Industrial Hygiene, (1943) United States Public Health Service, National Institutes of Health, Philadelphia, W.B. Saunders.

Ferguson, T., W.F. Harvey, and T.D. Hamilton (1933), "An Enquiry into the Relative Toxicity of Benzene and Toluene", Journal of Hygiene 33:547-579.

McCord, C., "The Present Status of Benzene (Benzol) Poisoning" (1929), Journal of the American Medical Association 93(4):280-283.

National Institute for Occupational Safety and Health (2007), "NIOSH Pocket Guide to Chemical Hazards,” DHHS Publication No. 2005-149.

National Toxicology Program (NTP), "Report on Carcinogens" (2005), Eleventh Edition, U.S. Department of Health and Human Services, Public Health Service, Washington D.C.

Rinsky, R.A., R.J. Young, and A.B. Smith (1981), "Leukemia in Benzene Workers," American Journal of Industrial Medicine 2:217-45.

Rinsky, R.A., A.B. Smith, R. Hornung, et al. (1987), "Benzene and Leukemia," New England Journal of Medicine 316:1044-1050.

Synder, R., "The Benzene Problem in Historical Perspective" (1984), Fundamental and 
Applied Toxicology 4

Synder, R., “Benzene and Leukemia” (2002), Critical Reviews in Toxicology 32(3):155-210.

Wallace, L., “Environmental Exposure to Benzene: An Update” (1996), Environmental Health Perspectives 104, Supplement 6, pp. 1129-1136.

World Health Organization (1993), “Benzene,” Environmental Health Criteria 150.

Zhang, L., D.A. Desmond, and M.T. Smith, “The Nature of Chromosomal Aberrations Detected in Humans Exposed to Benzene” (2002), Critical Reviews in Toxicology 32(1):1-42. 

This article discusses issues of general interest and does not give any specific legal or business advice pertaining to any specific circumstances.  Before acting upon any of its information, you should obtain appropriate advice from a lawyer or other qualified professional.

This article may not be duplicated, altered, distributed, saved, incorporated into another document or website, or otherwise modified without the permission of TASA. Contact marketing@tasanet.com for any questions.

Previous Article “Who Wrote That Email?”
Next Article Cases Written By An Expert
Tasa ID1351

Theme picker


  • Let Us Find Your Expert

  • Note: This form is to be completed by legal and insurance professionals ONLY. If you are a party in a case that requires an expert witness, please have your attorney contact TASA at 800-523-2319.

Search Experts

TASA provides a variety of quality, independent experts who meet your case criteria. Search our extensive list of experts now.

Search Experts